hub and Apple Pay functions; pg 30]; Vitamin Shoppe [ VSI ; pg 39]; drug and healthcare supplies distributor McKesson [ MCK ; CEO spotlight on John Hammergren ; pg 40]. GNW story http://online.barrons.com/news/articles/SB52133021052493823286804580158270334723144
The company is one of the smallest players in the medical distribution field, which is dominated by giants such as McKesson MCK and Cardinal Health CAH. Yet it has persistently increased its market share within the small niche it occupies (the
McKesson reported results for its fiscal first quarter ..... 177 fair value estimate. Helping to boost McKesson 's operations was the recent Celesio acquisition ..... a positive strategic move that enhances McKesson ’s supplier purchasing power and solidifies
the first half of 2014, we downgraded Actavis ACT "> ACT , Bayer BAYRY "> BAYRY , Mallinckrodt MNK "> MNK , McKesson MCK "> MCK , Novartis NVS "> NVS , and Zimmer ZMH "> ZMH because of these events. Also, in early 2014, Baxter BAX
* Magnetar says minority Celesio shareholders short changed
We believe McKesson ’s recent acquisition of major European ..... distribution advantages should benefit McKesson operationally. The firm will have the ..... Additionally, by acquiring Celesio, McKesson cements its status as the premier global
afternoon, everyone, and welcome to the McKesson Corporation Quarterly Earnings Call ..... Good afternoon and welcome to the McKesson fiscal 2014 fourth quarter earnings ..... joined today by John Hammergren, McKesson 's Chairman and CEO; and James
FRANKFURT, Dec 11 (Reuters) - German drugs wholesaler Celesio said its supervisory and management board recommended shareholders accept the $8.3 billion takeover offer from McKesson Corp . and viewed...
Sept 18 (Reuters) - Atossa Genetics Inc said an affiliate of U.S. drug wholesaler McKesson Corp would distribute its device used to collect breast fluid for cancer detection.
mandates will most likely build in more competition and less profitability into the sector. We will watch closely how McKesson handles the changing environment as we transfer coverage and evaluate our long-term analysis of the pharmaceutical services